AP215A - Substituted benzimidazoles, process for their preparation and their pharmaceutical use. - Google Patents
Substituted benzimidazoles, process for their preparation and their pharmaceutical use. Download PDFInfo
- Publication number
- AP215A AP215A APAP/P/1991/000285A AP9100285A AP215A AP 215 A AP215 A AP 215A AP 9100285 A AP9100285 A AP 9100285A AP 215 A AP215 A AP 215A
- Authority
- AP
- ARIPO
- Prior art keywords
- methyl
- compound
- compound according
- benzimidazole
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002206A SE9002206D0 (sv) | 1990-06-20 | 1990-06-20 | New compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9100285A0 AP9100285A0 (en) | 1991-07-31 |
AP215A true AP215A (en) | 1992-09-02 |
Family
ID=20379831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1991/000285A AP215A (en) | 1990-06-20 | 1991-06-19 | Substituted benzimidazoles, process for their preparation and their pharmaceutical use. |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP0535081A1 (de) |
JP (1) | JPH05507713A (de) |
CN (1) | CN1058212A (de) |
AP (1) | AP215A (de) |
AU (1) | AU649453B2 (de) |
BG (1) | BG97200A (de) |
CA (1) | CA2083714A1 (de) |
CZ (1) | CZ279772B6 (de) |
FI (1) | FI925766A (de) |
HU (1) | HUT62881A (de) |
IE (1) | IE912025A1 (de) |
IL (1) | IL98470A0 (de) |
IS (1) | IS3721A7 (de) |
LT (2) | LT3952B (de) |
LV (1) | LV10953A (de) |
MA (1) | MA22199A1 (de) |
NO (1) | NO924775L (de) |
NZ (1) | NZ238546A (de) |
OA (1) | OA09682A (de) |
PT (1) | PT98035A (de) |
RO (1) | RO110493B1 (de) |
SE (1) | SE9002206D0 (de) |
TN (1) | TNSN91049A1 (de) |
TW (1) | TW216418B (de) |
WO (1) | WO1991019711A1 (de) |
YU (1) | YU104191A (de) |
ZA (2) | ZA914296B (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9002043D0 (sv) * | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
SE9103776D0 (sv) * | 1991-12-19 | 1991-12-19 | Astra Ab | New compounds |
IS4232A (is) * | 1993-12-06 | 1995-06-07 | Astra Aktiebolag | Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
ATE281164T1 (de) | 2000-02-24 | 2004-11-15 | Kopran Res Lab Ltd | Oral verabreichbare säurebeständige geschwürbehandelnde benzimidazolderivate |
SE0101379D0 (sv) | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
DE60325709D1 (de) | 2002-04-09 | 2009-02-26 | Flamel Tech Sa | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
KR20060092255A (ko) | 2003-09-26 | 2006-08-22 | 알자 코포레이션 | 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법 |
TW200606163A (en) | 2004-04-22 | 2006-02-16 | Eisai Co Ltd | Imidazopyridine compound |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
US20070015782A1 (en) * | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
WO2007122686A1 (ja) * | 2006-04-14 | 2007-11-01 | Eisai R & D Management Co., Ltd. | ベンズイミダゾール化合物 |
PL2046334T3 (pl) | 2006-07-25 | 2015-02-27 | Vecta Ltd | Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI |
US20110009624A9 (en) * | 2006-10-13 | 2011-01-13 | Masato Ueda | Benzimidazole compounds having gastric acid secretion inhibitory action |
AU2009290712A1 (en) | 2008-09-09 | 2010-03-18 | Astrazeneca Ab | Method for delivering a pharmaceutical composition to patient in need thereof |
WO2010151216A1 (en) | 2009-06-25 | 2010-12-29 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
EP2519229A2 (de) | 2009-12-29 | 2012-11-07 | Novartis AG | Neue pharmazeutische darreichungsform zur behandlung von magensäurebedingten erkrankungen |
WO2011080500A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
EP2601947A1 (de) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Kombinationspräparat mit fester Dosierung zur Behandlung von Erkrankungen einhergehend mit Helicobacter pylori |
CA2860231A1 (en) | 2011-12-28 | 2013-07-04 | Pozen Inc. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
MX2019002726A (es) * | 2016-09-14 | 2019-09-23 | Jane Tseng Yufeng | Novedosos derivados sustituidos como inhibidores de la d-aminoacido oxidasa (daao). |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0166287A1 (de) * | 1984-06-16 | 1986-01-02 | Byk Gulden Lomberg Chemische Fabrik GmbH | Dialkoxypyridine, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel |
WO1986002646A1 (en) * | 1984-10-31 | 1986-05-09 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft M | New picoline derivatives, preparation process thereof, utilization thereof and drugs containing them |
WO1989005299A1 (en) * | 1987-12-11 | 1989-06-15 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel benzimidazole derivatives |
WO1989011479A1 (en) * | 1988-05-25 | 1989-11-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New fluoralkoxy compounds |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE418966B (sv) | 1974-02-18 | 1981-07-06 | Haessle Ab | Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan |
SE416649B (sv) | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
IN148930B (de) | 1977-09-19 | 1981-07-25 | Hoffmann La Roche | |
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
US4359465A (en) | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
CH644116A5 (de) | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
SE8300736D0 (sv) | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
SE8301182D0 (sv) | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
AU568441B2 (en) * | 1984-09-24 | 1987-12-24 | Upjohn Company, The | 2-(pyridylalkenesulfinyl) benzimidazole derivatives |
US4738975A (en) | 1985-07-02 | 1988-04-19 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, and use as anti-ulcer agents |
SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
NZ222495A (en) | 1986-11-21 | 1991-04-26 | Haessle Ab | Benzimidazole derivatives and pharmaceutical compositions |
DE3722810A1 (de) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung |
WO1989003830A1 (en) * | 1987-10-30 | 1989-05-05 | Aktiebolaget Hässle | 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss |
-
1990
- 1990-06-20 SE SE9002206A patent/SE9002206D0/xx unknown
-
1991
- 1991-06-05 ZA ZA914296A patent/ZA914296B/xx unknown
- 1991-06-05 ZA ZA914297A patent/ZA914297B/xx unknown
- 1991-06-11 AU AU80097/91A patent/AU649453B2/en not_active Ceased
- 1991-06-11 CA CA002083714A patent/CA2083714A1/en not_active Abandoned
- 1991-06-11 HU HU924033A patent/HUT62881A/hu unknown
- 1991-06-11 WO PCT/SE1991/000415 patent/WO1991019711A1/en not_active Application Discontinuation
- 1991-06-11 JP JP91511435A patent/JPH05507713A/ja active Pending
- 1991-06-11 EP EP91911659A patent/EP0535081A1/de not_active Withdrawn
- 1991-06-11 RO RO92-01581A patent/RO110493B1/ro unknown
- 1991-06-12 IL IL98470A patent/IL98470A0/xx unknown
- 1991-06-12 YU YU104191A patent/YU104191A/sh unknown
- 1991-06-12 TW TW080104582A patent/TW216418B/zh active
- 1991-06-14 NZ NZ238546A patent/NZ238546A/en unknown
- 1991-06-14 IE IE202591A patent/IE912025A1/en unknown
- 1991-06-18 MA MA22462A patent/MA22199A1/fr unknown
- 1991-06-19 TN TNTNSN91049A patent/TNSN91049A1/fr unknown
- 1991-06-19 PT PT98035A patent/PT98035A/pt not_active Application Discontinuation
- 1991-06-19 AP APAP/P/1991/000285A patent/AP215A/en active
- 1991-06-20 IS IS3721A patent/IS3721A7/is unknown
- 1991-06-20 CN CN91105024A patent/CN1058212A/zh active Pending
- 1991-06-20 CZ CS911894A patent/CZ279772B6/cs unknown
-
1992
- 1992-11-27 OA OA60306A patent/OA09682A/en unknown
- 1992-12-10 NO NO92924775A patent/NO924775L/no unknown
- 1992-12-18 FI FI925766A patent/FI925766A/fi not_active Application Discontinuation
- 1992-12-18 BG BG097200A patent/BG97200A/bg unknown
-
1993
- 1993-08-27 LV LV931045A patent/LV10953A/xx unknown
- 1993-12-30 LT LTIP1712A patent/LT3952B/lt not_active IP Right Cessation
- 1993-12-30 LT LTIP1713A patent/LT3977B/lt not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0166287A1 (de) * | 1984-06-16 | 1986-01-02 | Byk Gulden Lomberg Chemische Fabrik GmbH | Dialkoxypyridine, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel |
WO1986002646A1 (en) * | 1984-10-31 | 1986-05-09 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft M | New picoline derivatives, preparation process thereof, utilization thereof and drugs containing them |
WO1989005299A1 (en) * | 1987-12-11 | 1989-06-15 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel benzimidazole derivatives |
WO1989011479A1 (en) * | 1988-05-25 | 1989-11-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New fluoralkoxy compounds |
Also Published As
Publication number | Publication date |
---|---|
LTIP1712A (en) | 1995-08-25 |
IS3721A7 (is) | 1991-12-21 |
CZ279772B6 (cs) | 1995-06-14 |
LTIP1713A (en) | 1995-08-25 |
HU9204033D0 (en) | 1993-03-29 |
TW216418B (de) | 1993-11-21 |
MA22199A1 (fr) | 1992-04-01 |
FI925766A0 (fi) | 1992-12-18 |
JPH05507713A (ja) | 1993-11-04 |
LV10953A (lv) | 1995-12-20 |
IE912025A1 (en) | 1992-01-01 |
NO924775D0 (no) | 1992-12-10 |
SE9002206D0 (sv) | 1990-06-20 |
CA2083714A1 (en) | 1991-12-21 |
YU104191A (sh) | 1994-01-20 |
AU649453B2 (en) | 1994-05-26 |
AP9100285A0 (en) | 1991-07-31 |
CN1058212A (zh) | 1992-01-29 |
NO924775L (no) | 1992-12-10 |
ZA914297B (en) | 1992-03-25 |
OA09682A (en) | 1993-05-15 |
CS189491A3 (en) | 1992-04-15 |
HUT62881A (en) | 1993-06-28 |
WO1991019711A1 (en) | 1991-12-26 |
TNSN91049A1 (fr) | 1992-10-25 |
LT3977B (en) | 1996-06-25 |
NZ238546A (en) | 1994-03-25 |
LT3952B (en) | 1996-05-27 |
AU8009791A (en) | 1992-01-07 |
IL98470A0 (en) | 1992-07-15 |
RO110493B1 (ro) | 1996-01-30 |
BG97200A (bg) | 1993-12-24 |
PT98035A (pt) | 1992-03-31 |
FI925766A (fi) | 1992-12-18 |
ZA914296B (en) | 1992-03-25 |
EP0535081A1 (de) | 1993-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP215A (en) | Substituted benzimidazoles, process for their preparation and their pharmaceutical use. | |
EP0593463B1 (de) | Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung | |
EP0449940B1 (de) | Therapeutisch aktive verbindung und verfahren zu deren herstellung | |
US4965269A (en) | Therapeutically active chloro substituted benzimidazoles | |
EP0451188B1 (de) | Therapeutisch aktive substituierte Benzimidazole und Verfahren zu ihrer Herstellung | |
EP0449935B1 (de) | Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung | |
WO1987005021A1 (en) | Benzimidazoles and their pharmaceutical use | |
NZ246220A (en) | Substituted benzimidazol-1-yl methyl esters of phosphoric acid, medicaments and precursors | |
WO1995015962A1 (en) | Substituted benzimidazole, processes for its preparation and its pharmaceutical use | |
IE904248A1 (en) | Therapeutically active fluoro substituted benzimidazoles,¹processes for their preparation as well as their use |